You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Portugal

Jun 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Portugal with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Portugal, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Portugal for free:

The Consumer Health in Portugal market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Portugal?
  • What are the major brands in Portugal?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Healthy lifestyles drive market

The consumer healthcare market has benefited from the health and wellness trend, as well as the rise in the number of elderly people. As a consequence, demand for consumer health products continued to grow in 2010. Health consciousness among Portuguese consumers continues to increase, and there is growing interest in staying healthy and preventing future illnesses. This has had a positive influence on sales of consumer health products, as consumers are increasingly demanding more natural remedies, as well as products such as sports nutrition and vitamins, which are perceived to be a healthy aid to staying fit and preventing illnesses. The ageing of the Portuguese population is further strengthening this trend.

Obesity and overweight still a problem, however

Consumers were not just trying to prevent obesity for health reasons, but also because being slim is considered more attractive. The first OTC obesity drug in Portugal, Alli, was launched in 2009 with mixed reviews. In 2010 Alli continued to see healthy growth. Although consumers did not doubt the efficacy of the drug, its high cost and the fact that consumers had to stick to a strict low-fat diet to avoid side-effects meant the product was a moderate success.

Crisis slows sales

Despite the economic downturn, growth was maintained in consumer healthcare in 2010, with particularly strong performances by herbal/traditional remedies and sports nutrition. However, compared with the previous year and the review period as a whole, the market slowed down in 2010. Consumers opted to reduce their frequency of purchase or even to stop consuming some products perceived as non-essential. Moreover, Portuguese consumers preferred to chose low-priced options when possible. The few dynamism and innovation in consumer health also hampered sales.

Fragmented environment led by multinationals

Novartis remained the leading player in the consumer health market in 2010 due to the company’s strong position, particularly in cough, cold and allergy remedies, vitamins and dietary supplements, allergy care and smoking cessation aids. At GBO level multinational companies continued to dominate the consumer health environment. Multinational players benefit from the preference among consumers for self-medication, as this prompts them to opt for well-known brands with proven effectiveness. The competitive environment for consumer healthcare is characterised by many players holding low value shares.

Chemists and pharmacies still dominant

When it comes to distribution, chemists/pharmacies accounted for the majority of sales, mainly due to the consumer preference for professional advice when buying an over the counter (OTC) medicines. Due to the still recent law allowing parapharmacies/drugstores to sell OTC medicine, this channel is becoming increasingly important. Moreover, retailers have recently developed their own parapharmacy chains, thus increasing sales of this category. Healthfood shops, direct sales and Internet retailing held a small share of overall sales, and these channels focus mainly on vitamins and dietary supplements, slimming products and sports products. They were less successful in 2010 as they tend to offer more niche products at higher prices.

Moderate growth expected over forecast period

Growing awareness of the importance of healthy nutrition and a balanced lifestyle is likely to further support good growth of categories such as weight management products, given consumers’ rising health consciousness, allowing the continued positive performance of the market as a whole. However, the gloomy economic situation, and especially the budget deficit, remain key concerns. While consumer healthcare was among the industries less affected, job fears and economic insecurities remain a future threat to the industry.

Table of Contents

Table of Contents

Consumer Health in Portugal - Industry Overview

EXECUTIVE SUMMARY

Healthy lifestyles drive market

Obesity and overweight still a problem, however

Crisis slows sales

Fragmented environment led by multinationals

Chemists and pharmacies still dominant

Moderate growth expected over forecast period

KEY TRENDS AND DEVELOPMENTS

Lifestyle changes shape demand for OTC products

Obesity and overweight a real problem in Portugal

Economic recession marginally impacts sales in 2010

Multinationals dominate OTC market

Chemists/pharmacies dominate consumer health sales

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Portugal - Company Profiles

Coutinho & Alexandre Lda in Consumer Health (Portugal)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Coutinho & Alexandre Lda: Competitive Position 2010

Distrifa- Soluções de Saude Lda in Consumer Health (Portugal)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Distrifa- Soluções de Saude Lda: Competitive Position 2010

Laboratorio J Neves, Lda in Consumer Health (Portugal)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Laboratorio J Neves Lda: Competitive Position 2010

Laboratório Medinfar Produtos Farmacêuticos SA in Consumer Health (Portugal)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Laboratório Medinfar Produtos Farmacêuticos SA: Competitive Position 2010

Natiris-Centro Dietetico Lda in Consumer Health (Portugal)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Natiris-Centro Dietetico Lda: Competitive Position 2010

Adult Mouth Care in Portugal - Category Analysis

HEADLINES

TRENDS

  • The adult mouth care category continued to see steady growth in 2010, as consumers demonstrated greater interest in stronger mouthwashes offering more effective oral hygiene. The rising cost of trips to the dentist encouraged consumers to take better care of their oral health and self-medicate, driving sales of adult mouth care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Farma-Lepori SA continued to lead adult mouth care with a 41% value share in 2010, followed by Asta Médica Produtos Farmacêuticos Lda on 20%. Farma-Lepori SA maintained its position given the strength of its Tantum Verde brand, which overall remained the leading brand in the category. Its success is largely explained by its significant investments in television advertising. Asta Médica Produtos Farmacêuticos Lda managed to retain its position thanks to its brands Betadine and Bucagel.

PROSPECTS

  • Over the forecast period adult mouth care is expected to stagnate unless a more aggressive approach is implemented by the leading companies. Adult mouth care is predicted to see a 1% constant value CAGR over the forecast period. Higher growth is not expected as the category is nearing saturation.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Portugal - Category Analysis

HEADLINES

TRENDS

  • In 2010 analgesics in Portugal recorded the lowest retail value growth in the last decade. This slowdown was largely due to minimal product development and stagnant prices. Retail value growth for analgesics slowed to 1% in 2010, when the average growth rate in current value for the review period was 3%. This slowdown could also be attributed to the effects of the economic recession. Consumers in Portugal became extremely price-conscious over the last two years due to the global economic slowdown. As a result a shift towards cheaper options developed even for products such as analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline, Produtos Farmacêuticos Lda continued to lead analgesics in 2010, consolidating its position and gaining ground over the previous year, accounting in 2010 for 15% of total value sales. GlaxoSmithKline saw the best increase in value sales in 2010. Indeed, the company increased its value share more than one percentage point. Its brand Panadol saw the greatest increase thanks to its TV advertising campaign which continued to air during 2010. This enabled the company to gain some share to the detriment of other competitors more focused on push strategies. The company was also very active, advertising on TV and at point of sale.

PROSPECTS

  • Over the forecast period, manufacturers will continue to focus on products based on acetaminophen, and ibuprofen. Moreover, the increase in the number of older consumers, who suffer arthritis pain and increased risk of heart attack will create a positive growth environment for analgesics. Consumer trends at the end of the review period demonstrated a preference for products offering rapid or “instant” pain relief. This trend developed as a result of the increasingly busy pace of life in Portugal, which saw consumers looking for a quick fix when experiencing pain. Products which promote rapid pain relief are therefore likely to be growth drivers over the forecast period.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Portugal - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products are mostly natural, as there is a strict control over such products. Anxiolytics and standard medications aimed at controlling the quality of sleep can present problems such as dependency from those substances, which is a risk that is not associated with herbal and traditional remedies such as valerian.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010, the calming and sleeping products category continued to be led by Distrifa- Soluções de Saude Lda. As Owner of the Arkoampolas and Arkocapsulas brands, this player offers among its portfolio a wide range of calming and sleeping remedies. The company continued to invest strongly in its Arkoampolas brand, the popularity of which has increased.

PROSPECTS

  • The calming and sleeping category is expected to remain popular with consumers as stress and anxiety are common problems among Portuguese consumers. The higher concentration of city dwellers, particularly in Lisbon, and the growing number of older people expected over the forecast period, will extend the consumer base for OTC calming and sleeping products. Urban adults, due to their professional activities, busy lifestyles and financial concerns, will be more susceptible to stress and suffer from sleeping disorders. Elderly people also suffer more from anxiety and can have sleeping disorders brought on by the side effects of having to take other medications.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Portugal - Category Analysis

HEADLINES

TRENDS

  • As swine flu affected Portugal in 2009, Portuguese consumers took preventive actions to avoid becoming ill during the winter of 2010. As in previous years, sales of cough and cold products depend directly on the virulence of flu. As a result, sales of cough, cold and allergy (hay fever) remedies remained stagnant. Growth was much lower than the review period average. This was due to several factors. First of all, flu vaccination were free in Portugal for those aged over 65, and those in risk population groups. Before 2010 the flu vaccination had to be bought in pharmacies. The government decided that this free measure will be in place until 2012. Then the difficult economic crisis slowed down value sales. Portuguese consumers took preventive measures and in purchasing they turned to cheaper products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Although the Portuguese cough, cold and allergy (hay fever) remedies category is fragmented, Novartis Portugal SGPS Lda led at the end of the review period with a 16% value share in 2010. However, the company lost just over one percentage point compared with 2009. Novartis held first place thanks to the performance of several brands, such as Mebocaina, still leading the pharyngeal preparations category, Mebocatuss and Sinecod, present in cough remedies, or Vibrocil in decongestants.

PROSPECTS

  • Overall, the cough, cold and allergy remedies environment is predicted to see a slightly negative constant value CAGR over the forecast period. Lack of manufacturer investment in advertising and product innovation, particularly in the short term and until the economic situation in the country improves, will inhibit stronger growth. Compared with the review period, the forecast growth rate will be much lower. The financial crisis, which is expected to last until 2013, is also set to damage sales of cough and cold products as an increasing number of consumers switch to reimbursed products to save money.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2007-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2007-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Portugal - Category Analysis

HEADLINES

TRENDS

  • In recent years the pace of life in Portugal increased rapidly, and as a result many consumers found themselves with less and less time to prepare meals of a decent quality. As a result, the diets of contemporary Portuguese consumers now contain higher levels of fat, sugar and processed ingredients. This has led to less healthy dietary habits among Portuguese children and their parents, resulting in a growing number of Portuguese suffering digestive problems, thus boosting demand for digestive remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • Janssen-Cilag Farmacêutica Lda remained the leader in digestive remedies in 2010, with a value share of 15%, down two percentage points on the previous year. The company’s position is due to the popularity of its Kompensan brand in antacids and Imodium in diarrhoeal remedies. Novartis Portugal SGPS Lda ranked second with a value share of 13% of total sales thanks to its Pursenide brand in laxatives.

PROSPECTS

  • The expected poor performance of the Portuguese economy is set to play a key role over the forecast period as low disposable incomes result in an increasing number of patients switching from OTC consumption to Rx alternatives, and thus reimbursed medicines. The increasing proportion of elderly Portuguese, who usually suffer more from digestive problems, will partly support future demand. However, improving daily diets (such as the increasing intake of fibre-rich food) is expected to negatively impact demand for some remedies.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Portugal - Category Analysis

HEADLINES

TRENDS

  • Ear care grew by 1% in 2010 to reach EUR1 million. This category continued to show slow growth as prescriptions remain the driver of purchases: ears are considered very delicate organs and people prefer to visit a doctor when experiencing any ear problem. Also, there is a higher incidence of ear problems in children, and it is more common for parents to take children to a doctor. The category lacks dynamism, as there are no mass advertising campaigns to position its brands.

SWITCHES

COMPETITIVE LANDSCAPE

  • There was no significant variation in the position of the leading brands in 2010, largely due to a lack of manufacturers’ dynamism in terms of innovation, product development and advertising. The Otocalma brand from Salusif – Laboratorio de Produtos Quimicos e Farmaceuticos remained the leading brand in 2010 with a value share of 45%. The Otoceril brand from A Menarini Portugal – Farmacêutica ranked second with a value share of 27%. Both brands continued to benefit from their longstanding presence and high consumer brand loyalty.

PROSPECTS

  • Ear care is not expected to register strong growth over the forecast period as increased demand for products is not expected. The majority of the gains are expected to come from rising unit prices, which are only possible if the economy recovers.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Portugal - Category Analysis

HEADLINES

TRENDS

  • The demographic situation in Portugal is important regarding demand for emergency contraception. The birth-rate was low over the review period, and the government therefore attempted to improve the situation with different methods. However, it failed to improve couples’ opinion regarding their financial stability. Consequently, couples often had no choice but to avoid pregnancy, and demand for emergency contraception largely increased as a result.

COMPETITIVE LANDSCAPE

  • Fargin Produtos Farmacêuticos Lda with its brand NorLevo led the emergency contraception category in 2010 with a value share of 81%. Although it is more expensive than its direct competitor, Postinor, pharmacies remained more inclined to sell this brand, in part because it was the first emergency contraception medicine ever sold over the counter. The NorLevo brand was followed by Postinor from Bayer Portugal with a 19% value share. Over the review period the value share of the Postinor brand rose slightly to the detriment of NorLevo due to Postinor’s growing popularity in parapharmacies.

PROSPECTS

  • As birth control is expected to grow in Portugal, volume sales of emergency contraception are forecast to continue to fall, particularly in the short term. Growing information regarding the negative effects caused by its use and consumer preferences for safe and healthy contraceptive methods will continue to have a negative impact on demand. Consequently, unit prices will be the only variable able to push up value growth, and due to the decrease in demand, no important increase is expected over the forecast period. Overall, emergency contraception is expected to see a constant value CAGR of -3% over the forecast period.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Portugal - Category Analysis

HEADLINES

TRENDS

  • Compared with the review period, eye care recorded lower growth in 2010. Eye care in 2010 recorded a 2% increase to reach EUR11 million. Standard eye care recorded the fastest growth with an increase of 2% in current value terms. As Portuguese consumers opted to save money they traded down to cheaper products or chose not to purchase eye care products at all, as these were not considered of primary necessity. The first years of the review period saw positive growth, but as the recession hit Portugal growth continued but a slower pace.

SWITCHES

COMPETITIVE LANDSCAPE

  • Reckitt Benckiser Portugal Lda continued to lead eye care in 2010 with a retail value share of 17%. The company led thanks to its brand Optrex in standard eye care, holding a 32% value share in that niche. The brand benefited from high brand recognition among consumers, in part due to large investments in advertising made the company in previous years.

PROSPECTS

  • Forecast growth is good in terms of the potential demand for eye care products. The ageing population and increasing time spent in front of computer screens will force consumers to seek remedies, mostly artificial tears. However, the affordability of such products will remain an issue. The poor economy and fragile social payments system means that only the most necessary purchases will be bought by consumers. Eye care is projected to see a constant value CAGR of 0.5% over the forecast period to reach EUR11 million by 2015.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Portugal - Category Analysis

HEADLINES

TRENDS

  • Consumers view herbal/traditional products as the first attempt in treating and preventing health problems. There seems to be the popular belief that even if herbal/traditional remedies do not help they do no harm. Although there is a growing popularity of herbal products in Portugal, the category is suffering from the fact that Portuguese consumers are cutting down on expenditure on products not considered indispensable, including herbal/traditional medicines.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products remained a fragmented category at the end of the review period, characterised by several manufacturers. Cadbury Portugal Produtos de Confeitaria Lda retained the leadership with a value share of 7% thanks to its brands Halls and Vita-C. Distrifa- Soluções de Saude Lda and Natiris-Centro Dietetico were among the most important manufacturers in Portugal. Natiris-Centro Dietetico, for example, has been helping to develop this category through its production and retailing activities as it owns several healthfood shops under its Jardim Verde chain.

PROSPECTS

  • The recession and consequent shifts in consumer spending patterns had a negative effect on the development of herbal/traditional products. Despite the growing habit of self-medicating with herbal/traditional products, sales of this category will need to wait for better days to see a return to significant growth.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Portugal - Category Analysis

HEADLINES

TRENDS

  • Competition between medicated skin care and cosmetic products intensified in 2010 as consumer purchasing declined and cosmetics manufacturers increasingly positioned their brands as alternative treatments for the alleviation or prevention of minor skin conditions. Aggressive advertising campaigns by cosmetics manufacturers blurred the distinctions between the two types of products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated skin care is a fragmented environment characterised by a significant number of manufacturers. Bayer Portugal SA led with a value share of 12% in 2010, thanks to its brands Bepanthen and Vaginal Gyno-Canesten. Grünenthal SA ranked second on 7%. Grünenthal SA achieved its performance with the brand Halibut, very popular in Portugal in nappy (diaper) rash treatments.

PROSPECTS

  • Competition between medicated skin care and cosmetics products is expected to intensify over the forecast period as manufacturers of the latter continue to make claims regarding their ability to treat and prevent minor skin conditions. As a result, medicated skin care constant value sales are expected to decline by a total of less than 1%. Greater attention to personal hygiene by Portuguese consumers as part of the preventive healthcare trend will also hamper the development of medicated skin care, as it is likely to result in fewer people developing skin problems. As a result, the growth rate for the forecast period is much lower than seen over the review period. Sales of medicated skin care are predicted to decline slightly over the forecast period, by a -1% CAGR.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Portugal - Category Analysis

HEADLINES

TRENDS

  • After a period during which Portuguese consumers were trying quite hard to quit smoking, this was a fad that faded recently. On one hand there was the impact of the economic crisis, which put consumers off smoking due to increasing prices. However, the high unit prices of NRT products was also discouraging for consumers, which explains the much slower rate in 2010 compared with the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010 Janssen-Cilag Farmacêutica remained the leader in NRT smoking cessation aids with its Nicorette brand. The brand achieved a 46% value share of the total category in 2010. This player continued to benefit from the advantage of being the pioneer of this category.

PROSPECTS

  • The economic conditions and unemployment will put stronger pressure on Portuguese consumers’ disposable incomes in coming years. As a result, the forecast period is expected to see a decline in demand for NRT smoking cessation aids. Hence, NRT sales of smoking cessation aids are expected to drop – quite an important slowdown compared with the review period performance.

CATEGORY INDICATORS

  • Table 81 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 82 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 83 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 84 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 85 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 86 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 88 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Portugal - Category Analysis

HEADLINES

TRENDS

  • The image of sports nutrition experienced a change in Portugal. Traditionally sports nutrition is perceived as being mainly composed of products only to build body muscle as well as mainly masculine. This was the result of the advertisement and an emphasis on benefits and main aims of the different products. Consumers started to realise the importance of boosting the physical effort. The fact that players such as SportZone and Decathlon have increased their presence has also contributed to a more urban and younger spirit and sporting lifestyle.

COMPETITIVE LANDSCAPE

  • EcoNutraceuticos was the leading company in 2010. This position is due to the well-established brands Gold Nutrition and Twin Lab. Indeed, the company achieved a 42% value share at the end of the review period. This good result is underpinned by the fact that the company is present in different outlets, such as SportZone, and even via the Internet.

PROSPECTS

  • Despite the uncertainty and the financial instability in Portugal, this category is expected to post an increase as consumers are increasingly informed regarding its benefits and engage in sports as a health measure.

CATEGORY DATA

  • Summary 15 Sports Nutrition, Category Rankings 2010
  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Portugal - Category Analysis

HEADLINES

TRENDS

  • The general economic climate affected the performance of VDS as a whole. As these products are not perceived as essential, they are mostly sought when symptoms occur or if recommended by a doctor. Furthermore, there was little innovation from manufacturers which did not bring extra dynamism to the category.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Bayer Portugal lead sales with a 12% value share, in vitamins and dietary supplements, thanks mainly to performances of its Becozym, Supradyn and Redoxon vitamins brands. Whitehall Home Products de Portugal ranked second in 2010 due to the excellent performance of Centrum, which continued to lead multivitamins with a 6% share. Janssen Cilag Farmacêutica ranked third, with a 5% value share, essentially achieved via its Cecrisina vitamin brand.

PROSPECTS

  • Poor nutritional habits and stress create a favourable environment for the expansion of vitamins and dietary supplements. However, the economic recession and its harsh impact on the disposable income of Portuguese consumers, as well as promotions by manufacturers to retain volume sales, will ultimately cause value sales to post a marginal increase.

CATEGORY DATA

  • Summary 16 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 96 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 97 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 98 Dietary Supplements by Positioning 2005-2010
  • Table 99 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 100 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Vitamins Brand Shares by Value 2007-2010
  • Table 102 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Portugal - Category Analysis

HEADLINES

TRENDS

  • The relatively low growth can be attributed to the impact of the financial crisis on consumers’ disposable incomes, and a consequent reduction in expenditure in non-essential areas such as weight management products. Having enjoyed healthy growth rates during earlier years of the review period, slimming products were among the victims of the economic crisis. Despite being increasingly exposed to social pressure to control their weight, Portuguese consumers were less inclined to buy weight management products because of budget concerns.

COMPETITIVE LANDSCAPE

  • Herbalife Internacional Portugal SA led sales of weight management in 2010 with a value share of 26%. The company is well-established, and benefited from strong consumer loyalty for its brands, particularly in meal replacement slimming products. Nutricion & Santé Portugal ranked second with a value share of 24%. The company is largely well-established in grocery retail and pharmacies/parapharmacies with its brand Gerlinéa.

PROSPECTS

  • Sales of weight management products will continue to benefit from growing concerns regarding obesity in the country and weight will remain an important issue over the forecast period. The Portuguese population has already demonstrated a desire to live healthy and fitter lifestyles, and obesity, expected to increase, will prove a major stumbling block.

CATEGORY DATA

  • Table 105 Sales of Weight Management: Value 2005-2010
  • Table 106 Sales of Weight Management: % Value Growth 2005-2010
  • Table 107 Weight Management Company Shares 2006-2010
  • Table 108 Weight Management Brand Shares 2007-2010
  • Table 109 Forecast Sales of Weight Management: Value 2010-2015
  • Table 110 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Portugal - Category Analysis

HEADLINES

TRENDS

  • Sales in 2010 were driven by private label products. The poor economic backdrop, along with the limited display space in major distribution channels dedicated to branded offerings, proved crucial in boosted the strength of private label products. As a result their share increased steadily from 9% in 2001 to 15% in 2010, placing downwards pressure on unit prices.

COMPETITIVE LANDSCAPE

  • Beiersdorf Portuguesa Lda remained the leading manufacturer of wound care products with a value share of 25% in 2010. Its flagship brand, Hansaplast, continued to lead sales with a value share of 25%. Johnson & Johnson Lda, with its brands Compeed and Band-Aid, and Crefar Representacoes Lda with its Urgo brand, followed with 11%.

PROSPECTS

  • Consumers are likely to purchase wound care products when needed, and given the availability and ease of purchase, they are unlikely to hoard these products.

CATEGORY DATA

  • Table 111 Sales of Wound Care by Category: Value 2005-2010
  • Table 112 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 113 Wound Care Company Shares by Value 2006-2010
  • Table 114 Wound Care Brand Shares by Value 2007-2010
  • Table 115 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 116 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Artichoke
            • Guarana
            • Isoflavones
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Child-Specific Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Child-Specific Consumer Health
        • Child-Specific Analgesics
          • Child-Specific Acetaminophen
          • Child-Specific Aspirin
          • Child-Specific Combination Products - Analgesics
          • Child-Specific Diclofenac
          • Child-Specific Dipyrone
          • Child-Specific Ibuprofen
          • Child-Specific Ketoprofen
          • Child-Specific Naproxen
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Child-Specific Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Child-Specific Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by format
    • Analysis by positioning
    • Analysis by type
    • Herbal/traditional vs standard
    • Pricing
    • Smoking population - number of adult smokers
    • Smoking prevalence - % of adult population

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices % growth
    • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices % growth
    • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices % growth
    • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices % growth
    • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

    RELATED

    Country Report

    Consumer Lifestyle

    Future Demographic

    Country Report